EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan

Mukhammad Komil Ogli Amonov

Frontiers in Cardiovascular Medicine · 24.07.2026 · 13

DOI: 10.3389/fcvm.2026.1878203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 24.07.2026. Verfasst von Mukhammad Komil Ogli Amonov. Beteiligte Einrichtung: Department of Faculty and Hospital Therapy, Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Essential hypertension is a leading cause of chronic kidney disease, but conventional renal markers detect injury only after substantial nephron loss. Urinary nephrin, a slit-diaphragm protein released during podocyte injury, has been proposed as an early biomarker of hypertensive nephropathy, yet stage-specific data are scarce, particularly from Central Asia. In this single-centre, prospective study, we enrolled 60 adults with essential hypertension stratified by stage (I, II, III; n = 20 per group) in Bukhara, Uzbekistan; patients with diabetes, heart failure, primary kidney disease, or prior SARS-CoV-2 infection were excluded. Urinary nephrin, serum cystatin-C, TGF- β 1, aldosterone, and VEGF-A were measured by ELISA, and renal Doppler ultrasonography and an oral protein-loading test for renal functional reserve (RFR) were performed at baseline and after 6 months of an ACE inhibitor or angiotensin receptor blocker, with eplerenone where indicated. Urinary nephrin rose progressively across stages (91.9 ± 8.3, 124.9 ± 9.3, 164.5 ± 9.7 ng/mL) and was already elevated in stage I despite normal creatinine, cystatin-C, and eGFR. Nephrinuria correlated with systolic blood pressure (r = 0.58), aldosterone (r = 0.54), and microalbuminuria (r = 0.71), and inversely with eGFR (r = −0.74) and RFR (r = −0.76; all P < 0.01). After 6 months, urinary nephrin declined by 32%, 31%, and 23% across stages, with parallel reductions in TGF- β 1, VEGF-A, and aldosterone and partial RFR recovery. Urinary nephrin is elevated while conventional markers remain normal and responds to nephroprotective therapy, supporting its potential as an early biomarker of hypertensive kidney injury.

Schlagwörter

Stichwörter der Autor:innen

Central AsiaTGF-β1essential hypertensionnephroprotectionpodocyte dysfunctionrenal functional reserveurinary nephrin

Autor:innen und Institutionen

  • Department of Faculty and Hospital Therapy, Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan.

Zitieren

APA

Amonov, M. K. O. (2026). Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1878203

Vancouver

Amonov MKO. Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1878203

BibTeX
@article{Amonov2026,
  author = {Amonov, Mukhammad Komil Ogli},
  title = {Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1878203}
}
Kostenlos starten →